Metadata
- Name
- A Tolerability and Pharmacokinetics Study of SHR6390 in Advanced Melanoma Patients
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT02671513
- Description
- SHR6390 is a small molecular,oral potent, selective CDK4/6 inhibitor. The purpose of this
study is to investigate the safety/tolerability and the pharmacokinetic profile of SHR6390 in
Chinese advanced melanoma patients by using a "3+3" dose escalation.Preliminary efficacy will
be also investigated in this study. - Data or Study Types
- clinical trial
- Keywords
- Melanoma, Cycline-Dependent Kinase
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2016
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT02671513
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT02671513